We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
+22.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215B
AUM Growth
+$28.1B
Cap. Flow
+$1.96B
Cap. Flow %
0.91%
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189M
2
HON icon
Honeywell
HON
+$157M
3
AAPL icon
Apple
AAPL
+$124M
4
MSFT icon
Microsoft
MSFT
+$89M
5
AMZN icon
Amazon
AMZN
+$62.1M

Sector Composition

Rank Sector Weight
1 Technology 25.83%
2 Miscellaneous 25.2%
3 Financials 11.43%
4 Communication Services 6.64%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCWO icon
3576
374Water
SCWO
$51.4M
$3.74K ﹤0.01%
1,970
– –
MRKR icon
3577
Marker Therapeutics
MRKR
$17.8M
$3.69K ﹤0.01%
2,512
– –
TOMZ icon
3578
TOMI Environmental Solutions
TOMZ
$10.3M
$3.65K ﹤0.01%
1,477
– –
IMA
3579
ImageneBio Inc
IMA
$52M
$3.55K ﹤0.01%
602
– –
LSTA icon
3580
Lisata Therapeutics
LSTA
$15.6M
$3.51K ﹤0.01%
1,033
– –
TELA icon
3581
TELA Bio
TELA
$51.9M
$3.45K ﹤0.01%
4,604
– –
AIFF
3582
Firefly Neuroscience
AIFF
$24M
$3.35K ﹤0.01%
2,768
– –
PIII icon
3583
P3 Health Partners
PIII
$26.4M
$3.33K ﹤0.01%
308
– –
SBLK icon
3584
Star Bulk Carriers
SBLK
$3.41B
$3.32K ﹤0.01%
133
+111
+505% +$2.87K
LPSN
3585
DELISTED
LivePerson
LPSN
$3.24K ﹤0.01%
1,706
– –
SKYE icon
3586
Skye Bioscience
SKYE
$7.13M
$3.16K ﹤0.01%
570
– –
PASG icon
3587
Passage Bio
PASG
$14.5M
$3.11K ﹤0.01%
638
– –
DBGI
3588
Digital Brands Group
DBGI
$2.75M
$3.1K ﹤0.01%
103
– –
COCH icon
3589
Envoy Medical
COCH
$52.7M
$3K ﹤0.01%
3,788
– –
KLRS
3590
Kalaris Therapeutics
KLRS
$68.8M
$2.95K ﹤0.01%
725
– –
PSQH icon
3591
PSQ Holdings
PSQH
$19.1M
$2.73K ﹤0.01%
452
– –
FLUX icon
3592
Flux Power
FLUX
$9.75M
$2.71K ﹤0.01%
3,135
– –
SPAI
3593
Safe Pro Group Inc
SPAI
$92.9M
$2.6K ﹤0.01%
600
– –
XWEL icon
3594
XWELL
XWEL
$7.23M
$2.48K ﹤0.01%
2,383
– –
VTGN icon
3595
VistaGen Therapeutics
VTGN
$13.7M
$2.44K ﹤0.01%
10,809
– –
RDIB
3596
Reading International Class B
RDIB
$347M
$2.26K ﹤0.01%
263
– –
MODD icon
3597
Modular Medical
MODD
$16.3M
$2.25K ﹤0.01%
500
– –
SLND icon
3598
Southland Holdings
SLND
$35.9M
$2.22K ﹤0.01%
3,338
– –
UONEK icon
3599
Urban One Class D
UONEK
$17.4M
$2.19K ﹤0.01%
474
– –
XOS icon
3600
Xos
XOS
$45.2M
$2.1K ﹤0.01%
696
– –

Similar funds

Vanguard Global Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Financials.

  • Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
  • Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
  • Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
  • Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
  • Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
  • Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.